Cargando…
Erratum to: microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells
Autores principales: | Chen, Shuo, Chen, Xi, Xiu, Yin-Ling, Sun, Kai-Xuan, Zong, Zhi-Hong, Zhao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666147/ https://www.ncbi.nlm.nih.gov/pubmed/26626309 http://dx.doi.org/10.1186/s13048-015-0194-7 |
Ejemplares similares
-
microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells
por: Chen, Shuo, et al.
Publicado: (2014) -
The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression
por: Sun, Kai-Xuan, et al.
Publicado: (2016) -
DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR‐490‐3p and altering CDK1 expression
por: Wang, Li‐Li, et al.
Publicado: (2017) -
RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression
por: Chen, Xi, et al.
Publicado: (2015) -
MicroRNA-490-3p and −490-5p in carcinogenesis: Separate or the same goal?
por: Li, Yin, et al.
Publicado: (2021)